20.08.2012 • News

Bayer Sues Warner Chilcott for Patent Infringement

Warner Chilcott said German drugmaker Bayer filed a complaint against the U.S. pharmaceutical company, alleging that Warner's oral contraceptive drug Lo Loestrin FE infringes a Bayer patent. According to the complaint filed in a U.S. district court, Bayer is seeking an injunction on the product along with unspecified monetary damages, Warner said in a filing. New Jersey-based Warner said it would defend the litigation as it believes the complaint lacks merit.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

Article

The State of the US Specialty Chemicals Industry
Reshaping Specialty Chemicals Manufacturing

The State of the US Specialty Chemicals Industry

SOCMA's Jenn Klein examines how specialty chemical manufacturers — the invisible backbone behind pharmaceuticals, electronics, agriculture, and energy — are navigating supply chain shifts, policy uncertainty, and constant change while remaining resilient, disciplined, and focused on execution.

most read